Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature

被引：9
|
作者：
John, Alexius [1 ,2 ]
Spain, Lavinia [2 ]
Hamid, Anis A. [1 ,2 ,3 ,4 ]
机构：
[1] Eastern Hlth, Dept Med Oncol, Melbourne, Vic 3128, Australia
[2] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3128, Australia
[4] Univ Melbourne, Dept Surg, Melbourne, Vic 3010, Australia
来源：
CURRENT ONCOLOGY | 2023年 / 30卷 / 01期
关键词：
non-clear cell; renal cell carcinoma; papillary; hereditary leiomyomatosis and renal cell cancer; chromophobe; medullary; collecting duct; COMPREHENSIVE MOLECULAR CHARACTERIZATION; OPEN-LABEL; PHASE-II; SUNITINIB; CABOZANTINIB; EPIDEMIOLOGY; MULTICENTER; MONOTHERAPY; EXPRESSION; CRIZOTINIB;
D O I：
10.3390/curroncol30010070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes. To date, clinical trials evaluating the use of immunotherapies and targeted therapies have predominantly been conducted in patients with clear cell histology. A comprehensive review of the literature has been undertaken in order to describe molecular pathogenic mechanisms pertaining to each nccRCC subtype, and concisely summarise findings from therapeutic trials conducted in the nccRCC space.
引用
下载
收藏
页码：923 / 937
页数：15
相关论文
共 50 条
  • [11] Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
    Xu K.Y.
    Wu S.
    Biomarker Research, 3 (1)
  • [12] Targeted therapies for non-clear renal cell carcinoma
    Eric A. Singer
    Gennady Bratslavsky
    W. Marston Linehan
    Ramaprasad Srinivasan
    Targeted Oncology, 2010, 5 : 119 - 129
  • [13] Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma
    Barth, Dominik A.
    Slaby, Ondrej
    Klec, Christiane
    Juracek, Jaroslav
    Drula, Rares
    Calin, George A.
    Pichler, Martin
    CANCERS, 2019, 11 (10)
  • [14] Targeted therapies for non-clear renal cell carcinoma
    Singer, Eric A.
    Bratslavsky, Gennady
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    TARGETED ONCOLOGY, 2010, 5 (02) : 119 - 129
  • [15] Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
    Heng, Daniel Y. C.
    Bukowski, Ronald M.
    ONCOLOGY REVIEWS, 2007, 1 (03) : 170 - 176
  • [16] The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma
    Naik, Priyanka
    Dudipala, Harshitha
    Chen, Yu-Wei
    Rose, Brent
    Bagrodia, Aditya
    Mckay, Rana R.
    THERAPEUTIC ADVANCES IN UROLOGY, 2024, 16
  • [17] Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
    Sepe, Pierangela
    Ottini, Arianna
    Pircher, Chiara Carlotta
    Franza, Andrea
    Claps, Melanie
    Guadalupi, Valentina
    Verzoni, Elena
    Procopio, Giuseppe
    CANCERS, 2021, 13 (15)
  • [18] Non-Clear Cell Renal Cell Carcinoma, Part 2: Therapy
    Valenca, Loana B.
    Hirsch, Michelle S.
    Choueiri, Toni K.
    Harshman, Lauren C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (06) : 383 - 391
  • [19] Targeted therapies and the treatment of non-clear cell renal cell carcinoma
    Bellmunt, J.
    Dutcher, J.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1730 - 1740
  • [20] Non-Clear Cell Renal Cell Carcinoma, Part 1: Histology
    Valenca, Loana B.
    Hirsch, Michelle S.
    Choueiri, Toni K.
    Harshman, Lauren C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (05) : 308 - 313
12345